Head & neck · 2026
Cumulative Incidence and Risk of Depression After Opioid Use in Head and Neck Cancer Patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Osazuwa-Peters Nosayaba, Hunter Alexandra E, Salas Joanne, Chrusciel Timothy, Kahmke Russel R, Bates Nicole E, Scherrer Jeffrey F
Аннотация
BACKGROUND: This study examined the relationship between postoperative opioid duration and new-onset depression following head and neck cancer (HNC) surgery.
METHODS: We conducted a retrospective review of opioid-naïve patients undergoing HNC surgery from 2007 to 2020, using national Veterans Health Administration claims data. Postoperative opioid duration was categorized as 1-30 days, 31-90 days, or > 90 days (long-term opioid therapy [LTOT]). The primary outcome was new-onset depression within 24 months. Competing risk survival models with entropy balancing evaluated associations.
RESULTS: Among 9148 patients, 24.3% received LTOT. Rates of new-onset depression per 1000 person-years were 46.8 (1-30 days), 70.2 (31-90 days), and 88.4 (LTOT). LTOT was associated with a 20% increased risk of depression compared with 1-30 days of use. LTOT was associated with higher rates of comorbidities, non-cancer pain, anxiety, substance use, and preoperative benzodiazepine use.
CONCLUSION: LTOT was independently associated with higher risk of depression after HNC surgery.
METHODS: We conducted a retrospective review of opioid-naïve patients undergoing HNC surgery from 2007 to 2020, using national Veterans Health Administration claims data. Postoperative opioid duration was categorized as 1-30 days, 31-90 days, or > 90 days (long-term opioid therapy [LTOT]). The primary outcome was new-onset depression within 24 months. Competing risk survival models with entropy balancing evaluated associations.
RESULTS: Among 9148 patients, 24.3% received LTOT. Rates of new-onset depression per 1000 person-years were 46.8 (1-30 days), 70.2 (31-90 days), and 88.4 (LTOT). LTOT was associated with a 20% increased risk of depression compared with 1-30 days of use. LTOT was associated with higher rates of comorbidities, non-cancer pain, anxiety, substance use, and preoperative benzodiazepine use.
CONCLUSION: LTOT was independently associated with higher risk of depression after HNC surgery.